Clinical
News
EMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartan
HM20 Virtual
HM20 Virtual: Key takeaways for the pediatric hospitalist
Here are some key concepts and takeaways from HM20 Virtual for the pediatric hospitalist.
News
Stroke may be the first symptom of COVID-19 in younger patients
Nearly half of patients under the age of 50 were asymptomatic at the time of stroke onset.
News
CDC flips, acknowledges aerosol spread of COVID-19
The update acknowledges the existence of some published reports showing limited, uncommon circumstances where people with COVID-19 infected others...
News
Substance use tied to increased COVID-19 risk
Those with a recent diagnosis of SUD were eight times more likely to develop COVID-19, compared with those without such a diagnosis.
News
Minorities bear brunt of pediatric COVID-19 cases
COVID-19 infection rates were significantly higher in children in lowest three quartiles of median family income.
News
COVID-19 may discourage pediatric flu vaccination
Approximately one-third of parents whose children received no flu vaccine last year said the pandemic made them less likely to vaccinate their...
News
Inside the flawed White House testing scheme that did not protect Trump
An early antigen test used by the White House was woefully inaccurate. But the new antigen test the White House is using has not been...
News
Dapagliflozin’s CKD performance sends heart failure messages
The recently reported DAPA-CKD trial results focused on patients with renal disease, but the findings also resonate for heart failure clinicians...
News
Real-world safety, efficacy found for fecal transplants
The study didn't yield any findings on indications other than Clostridioides difficile. "In no way, shape, or form does it mean you can use it for...